ReviewFrontiers in immunology2026
Health risk analysis of micro-and nanoplastic exposure via the microbiota-gut-brain axis.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gut-Mediated Systemic Toxicity of Micro- and Nanoplastics: Nanoscale Biointerface Properties, Microbiota-Metabolite Crosstalk, and Evidence Across Gut-Organ Axes.Nanomaterials (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As global plastic pollution continues to intensify, micro- and nanoplastics have emerged as novel environmental pollutants threatening human health. These particles enter the human body through dietary ingestion, inhalation, and skin contact,accumulating within the gastrointestinal tract. Their disruption of the intestinal microbiota has become a recent research focus. Studies indicate that micro- and nanoplastics can interfere with the normal mechanisms of the microbiota-gut-brain axis via neural, immune, and endocrine pathways, thereby inducing or exacerbating diseases. This paper reviews the exposure pathways and intestinal accumulation characteristics of micro- and nanoplastics in humans, the composition of normal gut microbiota and their metabolic products, elucidates the functional pathways of the microbiota-gut-brain axis and the potential impacts of microplastics upon entering the human body, and summarises the current research status, limitations, and future prospects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.